Which #vaccines or mAbs would do the most to curb #AMR, and at what cost?
#PrIMAVeRa_AMR is building a tool to help answer that question. EVI & @isciiisalud.bsky.social led a stakeholder meeting with participants from industry, policy, public health & research.
www.primavera-amr.eu/post/primave...
